Revance Therapeutics, Inc. ( NASDAQ:RVNC – Get Free Report )'s stock price traded down 3.7% during mid-day trading on Wednesday . The company traded as low as $23.65 and last traded at $23.68. 563,446 shares traded hands during mid-day trading, a decline of 61% from the average session volume of 1,443,986 shares. The stock had previously closed at $24.60. Wall Street Analysts Forecast Growth A number of research analysts recently issued reports on the stock. Piper Sandler raised their target price on shares of Revance Therapeutics from $39.

https://www.dailypolitical.com/2023/07/14/revance-therapeutics-nasdaqrvnc-shares-down-3-7.html

#dailypolitical